Answer
Steglatro has no or negligible influence on driving or using machines, but patients should be warned about hypoglycaemia when combined with insulin or an insulin secretagogue and the increased risk of volume-depletion reactions such as dizziness on standing.
Sources for this answer
- Steglatro 5 mg and 15 mg film-coated tabletsMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 9Document updated
Sources checked